P&K Skin Research Center Co.,Ltd.
P&K Skin Research Center Co.,Ltd., founded in 2010 and listed on KOSDAQ in 2020, is a research center specializing in human application tests for skin-applied products.
As of 2026-10-10, P&K Skin Research Center Co.,Ltd. has 13 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2010 and listed on KOSDAQ in 2020, P&K Skin Research Center Co.,Ltd. specializes in human application tests on skin-applied products. It provides human application and in-vitro tests, plus big-data consulting, for cosmetics, beauty devices, and health functional foods. Revenue is split among cosmetics test services, other test services for foods and devices, and other in-vitro services.
Publications
PubMed · affiliation-matched- Photoprotective Effects of Quercetin and Hesperidin in Polymorphous Light Eruption: A Comparative Study with Alpha-Glucosylrutin.
Current issues in molecular biology · 2025-07 · Choi YS, Park SH, Jung I 외 5
- Independent and Combined Effects of Particulate Matter and Sleep Deprivation on Human Skin Barrier.
Annals of dermatology · 2025-06 · Kwon IJ, Lee EJ, Park JH 외 10
- Electroencephalography-based neural indicators of texture preference for cosmetic formulations.
Frontiers in neuroscience · 2025-01 · Cheon HR, Kwon G, Kim Y 외 5
- Oral Intake of Enzymatically Decomposed AP Collagen Peptides Improves Skin Moisture and Ceramide and Natural Moisturizing Factor Contents in the Stratum Corneum.
Nutrients · 2021-12 · Jung K, Kim SH, Joo KM 외 6
- Identifi cation of the Underlying Genetic Factors of Skin Aging in a Korean Population Study.
Journal of cosmetic science · 2021-01 · Oh Kim J, Park B, Yoon Choi J 외 8
- Equivalence of in vitro and in vivo methods for assessing the effectiveness of anti-particulate matter pollution products.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2021-01 · Kim S, Kim S, Shon D 외 3
- Synergistic effects of using novel home-use 660- and 850-nm light-emitting diode mask in combination with hyaluronic acid ampoule on photoaged Asian skin: A prospective, controlled study.
Journal of cosmetic dermatology · 2020-10 · Kim DS, Song KU, Lee HK 외 4
- A study of skin characteristics with long-term sleep restriction in Korean women in their 40s.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2020-03 · Jang SI, Lee M, Han J 외 6
- Anti-Wrinkle Benefits of Peptides Complex Stimulating Skin Basement Membrane Proteins Expression.
International journal of molecular sciences · 2019-12 · Jeong S, Yoon S, Kim S 외 10
- A new technique for evaluating heel xerosis grade and the effects of moisturizer on heel skin dryness.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2018-11 · Choi JY, Kim EJ, Jang SI 외 3
Show 3 more publications
- Efficacy and safety of a novel, soluble microneedle patch for the improvement of facial wrinkle.
Journal of cosmetic dermatology · 2018-04 · Hong JY, Ko EJ, Choi SY 외 4
- Unwanted hair growth induced by topical epidermal growth factor during wound healing: true or myth?
International wound journal · 2016-10 · Hyun MY, Suk JM, Yoo KH 외 3
- Efficacy of adenosylcobalamin in relieving xerotic pruritus symptoms of atopic dermatitis.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2014-02 · Kim HK, Kim BJ, Suk JM 외 5
Patents
KIPRIS · applicant-matchedPublished · 2025-02 · Application 1020250020824
Registered · 2024-06 · Application 1020240072322
Registered · 2022-12 · Application 1020220189261
Registered · 2022-05 · Application 1020220065247
Published · 2021-11 · Application 1020210164590
Registered · 2021-10 · Application 1020210142556
PCT · Published · 2021-10 · Application PCT/KR2021/013853
Registered · 2021-08 · Application 1020210107225
PCT · Published · 2021-06 · Application PCT/KR2021/007477
EP · Registered · 2021-04 · Application 21803025.2
Show 17 more patents
PCT · Published · 2021-04 · Application PCT/KR2021/005322
Registered · 2020-10 · Application 1020200130605
Registered · 2020-06 · Application 1020200076321
Registered · 2020-05 · Application 1020200056015
CN · Published · 2020-03 · Application 202080026034.1
EP · Registered · 2020-03 · Application 20782013.5
US · Registered · 2020-03 · Application 17599742
PCT · Published · 2020-03 · Application PCT/KR2020/003998
Registered · 2019-12 · Application 1020190173477
Registered · 2019-12 · Application 1020190173480
Registered · 2019-12 · Application 1020190173481
Registered · 2019-12 · Application 1020190173478
Registered · 2019-12 · Application 1020190173479
Registered · 2019-03 · Application 1020190036479
CN · Published · 2017-09 · Application 201780055737.5
PCT · Published · 2017-09 · Application PCT/KR2017/009919
Registered · 2016-09 · Application 1020160116229
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive1
- OpenAIOAI-SearchBot5
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 5 AI engines · last read Sep 28, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for P&K Skin Research Center Co.,Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryBiotech & Drug Discovery
KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.
Drug delivery system company behind the long-acting injectable platform IVL-DrugFluidic and the LNP delivery platform IVL-GeneFluidic.
Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.
EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.
A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.
Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.
KOSDAQ-listed antibody biotech developing the next-generation immuno-oncology candidate Multi-AbKine on its fully human antibody library Ymax®-ABL.
A holding company overseeing 54 affiliates including its main biopharmaceutical subsidiary GC, with no direct product manufacturing of its own.
Founded in 2015 and listed on KOSPI in 2021, Prestige BioPharma develops antibody biosimilars and novel antibody drugs including Tuznue.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
SillaJen, Inc., founded in 2006 and listed on KOSDAQ in 2016, develops the oncolytic virus immunotherapy Pexa-Vec.
A vaccine specialist developing in-house products such as SKYCellflu and SKYZoster while also serving as CDMO for AstraZeneca and Novavax.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition